marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
China Pharma Holdings Financial Ratios 2011-2024 | CPHI
Annual Financial Ratios China Pharma Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.1 | -0.7 | -10.8 | -0.9 | -1.2 | -0.8 | -1.2 | -0.4 | -0.5 | -0.9 | 2.4 | 1.7 |
P/S |
0.2 | 0.0 | 0.2 | 2.8 | 1.7 | 1.0 | 1.1 | 0.7 | 0.3 | 0.5 | 0.6 | 0.2 | 0.4 |
EPS |
-0.9 | -3.8 | -0.7 | -0.1 | -0.5 | -0.2 | -0.4 | -0.2 | -0.3 | -0.9 | -0.5 | 0.1 | 0.4 |
EV (Enterprise Value) |
8.84 M | 11.8 M | 14 M | 43.1 M | 30.2 M | 26.6 M | 29.7 M | 27.8 M | 24.4 M | 33.6 M | 37.4 M | 21.6 M | 42.9 M |
EBITDA per Share |
- | -0.81 | 0.05 | 0.00496 | -0.0106 | -0.00241 | 0.00433 | -0.000661 | -0.0103 | -0.0126 | -0.143 | 0.203 | 0.534 |
EV/EBITDA |
51.8 | 172.7 | -46.7 | -171.0 | 116.5 | -635.7 | -27.1 | -37.9 | -4.8 | 1.3 | 1.4 | ||
PEG |
0.0 | 0.0 | -0.02 | -0.13 | 0.01 | -0.03 | 0.01 | -0.03 | -0.01 | 0.02 | 0.0 | -0.03 | -0.09 |
P/B |
0.2 | 0.1 | 0.4 | 3.9 | 2.0 | 0.4 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
P/CF |
-1.8 | -0.9 | -8.9 | -34.0 | 38.8 | 10.5 | 21.0 | 4.0 | 5.9 | -10.3 | -1.8 | -8.1 | -107.8 |
ROE % |
-41.30 | -92.61 | -56.49 | -35.81 | -224.11 | -35.60 | -44.76 | -15.59 | -21.21 | -24.51 | -15.05 | 3.11 | 13.52 |
ROA % |
-18.69 | -22.34 | -15.01 | -13.58 | -93.10 | -23.69 | -32.15 | -11.69 | -15.85 | -19.72 | -12.69 | 2.83 | 12.32 |
ROCE % |
-36.91 | -82.73 | -47.53 | -25.36 | -27.81 | -9.52 | -6.12 | -4.56 | -4.79 | -1.98 | -5.39 | 4.96 | 15.44 |
Current Ratio |
1.8 | 1.3 | 1.4 | 0.5 | 0.6 | 0.9 | 1.3 | 1.7 | 2.0 | 3.8 | 7.0 | 7.7 | 8.0 |
DSO |
24.1 | 10.2 | 10.1 | 19.6 | 24.3 | 32.8 | 69.0 | 99.0 | 110.7 | 374.6 | 508.0 | 444.4 | 313.7 |
DIO |
167.2 | 133.5 | 138.4 | 151.7 | 138.7 | 178.2 | 217.7 | 216.0 | 186.7 | 287.3 | 270.6 | 328.2 | 212.5 |
DPO |
40.9 | 33.8 | 42.4 | 50.6 | 52.8 | 37.4 | 38.8 | 90.4 | 54.6 | 47.8 | 20.6 | 25.7 | 21.8 |
Operating Cycle |
191.3 | 143.6 | 148.4 | 171.3 | 163.1 | 211.0 | 286.6 | 315.1 | 297.5 | 661.9 | 778.6 | 772.6 | 526.2 |
Cash Conversion Cycle |
150.4 | 109.8 | 106.0 | 120.8 | 110.2 | 173.6 | 247.9 | 224.6 | 242.9 | 614.0 | 758.0 | 746.9 | 504.4 |
All numbers in USD currency
Quarterly Financial Ratios China Pharma Holdings
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | -0.09 | - | -0.29 | -0.35 | -0.06 | - | -0.16 | -0.18 | -0.22 | - | -0.02 | -0.02 | -0.02 | - | -0.02 | - | -0.02 | - | -0.02 | -0.02 | -0.01 | - | -0.04 | -0.02 | -0.01 | - | -0.05 | -0.05 | -0.02 | - | -0.04 | -0.06 | -0.04 | - | 0.07 | 0.03 | -0.09 | - | -0.15 | -0.2 | -0.05 | - | -0.05 | -0.1 | -0.06 | - | 0.03 | 0.04 | 0.06 | - | 0.11 | 0.12 | 0.12 |
EBITDA per Share |
-0.03 | -0.05 | - | -0.03 | 0.11 | 0.03 | - | -0.01 | -0.16 | -0.05 | - | 0.04 | 0.01 | - | - | 0.02 | 0.03 | - | - | 0.04 | 0.02 | 0.01 | - | 0.01 | 0.02 | 0.02 | - | 0.01 | -0.01 | - | - | 0.02 | -0.01 | -0.01 | - | 0.14 | 0.08 | -0.06 | - | -0.11 | -0.18 | -0.05 | - | -0.04 | -0.09 | -0.07 | - | 0.06 | 0.07 | 0.09 | - | 0.16 | 0.15 | 0.13 |
ROE % |
-61.99 | -58.49 | -36.54 | -64.44 | -79.61 | -88.06 | -69.25 | -81.31 | -65.47 | -56.04 | -35.41 | -48.03 | -48.58 | -35.78 | -20.71 | -28.30 | -23.27 | -32.51 | -21.18 | -27.33 | -25.89 | -20.16 | -10.46 | -15.55 | -14.50 | -16.48 | -12.65 | -15.62 | -13.50 | -12.35 | -9.77 | -5.74 | 1.27 | 6.99 | -0.01 | -6.84 | -17.70 | -28.57 | -18.74 | -25.94 | -26.32 | -20.36 | -10.35 | -6.40 | 4.75 | 11.18 | 8.91 | 11.22 | 9.58 | 10.07 | 9.45 | 2.31 | 3.56 | 3.58 |
ROA % |
-28.52 | -23.99 | -11.58 | -16.46 | -16.28 | -17.46 | -14.73 | -19.28 | -18.94 | -18.12 | -12.55 | -17.33 | -17.57 | -13.37 | -7.85 | -11.00 | -9.37 | -13.20 | -8.80 | -12.89 | -13.83 | -12.28 | -6.96 | -10.62 | -10.19 | -11.79 | -9.09 | -11.32 | -9.89 | -9.20 | -7.33 | -4.32 | 0.93 | 5.21 | -0.01 | -5.24 | -13.48 | -21.78 | -14.34 | -20.42 | -21.27 | -16.96 | -8.73 | -5.14 | 4.53 | 10.16 | 8.11 | 10.21 | 8.73 | 9.17 | 8.61 | 2.10 | 3.24 | 3.26 |
ROCE % |
-58.76 | -52.62 | -30.67 | -54.96 | -67.58 | -76.47 | -60.74 | -71.86 | -58.69 | -50.86 | -32.38 | -44.28 | -45.06 | -32.58 | -18.45 | -25.43 | -20.52 | -29.61 | -18.75 | -25.15 | -24.56 | -19.27 | -9.72 | -14.50 | -12.87 | -14.96 | -11.58 | -14.21 | -12.07 | -10.89 | -8.64 | -4.25 | 2.78 | 8.53 | 1.20 | -5.26 | -16.12 | -27.30 | -18.19 | -20.21 | -15.77 | -10.16 | -7.86 | -6.77 | -3.66 | 1.41 | 4.88 | 9.06 | 12.16 | 14.71 | 11.98 | 4.19 | 4.04 | 3.75 |
Current Ratio |
1.9 | 2.1 | 1.8 | 1.7 | 1.4 | 1.4 | 1.3 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 3.0 | 3.0 | 3.0 | 3.0 | 3.5 | 3.5 | 3.5 | 3.5 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.3 | 4.3 | 4.3 | 4.2 | 6.4 | 6.4 | 6.4 | 6.4 | 11.1 | 11.1 | 11.1 | 11.1 | 11.2 | 11.2 | 11.2 | 11.2 |
DSO |
24.4 | 37.5 | - | 11.6 | 8.3 | 12.3 | - | 2.3 | 2.7 | 1.9 | - | 2.6 | 11.5 | 20.2 | - | 21.5 | 17.6 | 38.5 | - | 24.4 | 22.6 | 24.2 | - | 36.4 | 26.4 | 40.5 | - | 66.2 | 71.7 | 87.4 | - | 61.7 | 54.4 | 76.5 | - | 235.6 | 242.5 | 261.7 | - | 407.4 | 369.9 | 449.5 | - | 507.6 | 613.0 | 712.8 | - | 509.6 | 436.7 | 406.3 | - | 300.9 | 324.5 | - |
DIO |
149.8 | 154.1 | - | 172.1 | 281.3 | 171.7 | - | 139.2 | 184.2 | 186.4 | - | 121.4 | 129.2 | 161.2 | - | 143.7 | 129.0 | 212.0 | - | 163.4 | 136.1 | 173.5 | - | 258.3 | 177.8 | 204.1 | - | 213.3 | 257.7 | 243.8 | - | 240.3 | 218.0 | 258.2 | - | 237.0 | 195.4 | 257.1 | - | 344.6 | 376.5 | 410.6 | - | 384.0 | 385.0 | 454.6 | - | 371.4 | 317.2 | 282.4 | - | 205.8 | 225.0 | - |
DPO |
15.0 | 26.0 | - | 27.9 | 46.3 | 38.8 | - | 18.1 | 32.8 | 47.7 | - | 25.8 | 35.0 | 51.3 | - | 47.9 | 43.0 | 75.6 | - | 62.2 | 51.8 | 48.7 | - | 54.2 | 37.3 | 39.2 | - | 38.0 | 45.9 | 74.7 | - | 100.6 | 91.3 | 83.7 | - | 69.3 | 57.1 | 55.3 | - | 57.4 | 62.7 | 45.5 | - | 29.2 | 29.3 | 35.1 | - | 29.0 | 37.9 | 37.9 | - | 19.9 | 10.2 | - |
Operating Cycle |
174.2 | 191.5 | - | 183.7 | 289.6 | 174.9 | - | 141.5 | 186.8 | 188.4 | - | 124.0 | 140.7 | 181.4 | - | 165.2 | 146.6 | 250.6 | - | 187.8 | 158.7 | 197.7 | - | 294.7 | 204.2 | 244.6 | - | 279.5 | 329.4 | 331.2 | - | 302.0 | 272.4 | 334.7 | - | 472.6 | 437.9 | 518.7 | - | 752.0 | 746.4 | 860.0 | - | 891.6 | 998.0 | 1167.4 | - | 881.0 | 753.9 | 688.7 | - | 506.6 | 549.5 | - |
Cash Conversion Cycle |
159.2 | 165.5 | - | 155.8 | 243.3 | 136.1 | - | 123.4 | 154.0 | 140.7 | - | 98.2 | 105.7 | 130.1 | - | 117.3 | 103.6 | 175.0 | - | 125.6 | 106.9 | 149.0 | - | 240.5 | 166.8 | 205.4 | - | 241.5 | 283.5 | 256.5 | - | 201.4 | 181.2 | 251.1 | - | 403.3 | 380.8 | 463.4 | - | 694.6 | 683.7 | 814.6 | - | 862.4 | 968.7 | 1132.2 | - | 852.0 | 715.9 | 650.7 | - | 486.7 | 539.2 | - |
All numbers in USD currency